Jessica Tassan
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
59
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Downgrades: Neutral | $392 → $274 | $260.71 | +5.10% | 2 | Oct 3, 2024 | |
| OSCR Oscar Health | Reiterates: Overweight | $28 | $17.65 | +58.64% | 4 | Sep 10, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $14 → $11 | $7.70 | +42.86% | 9 | Aug 26, 2024 | |
| MPLN MultiPlan | Reiterates: Neutral | $80 → $40 | $9.16 | +336.68% | 2 | Aug 7, 2024 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $8 → $10 | $12.95 | -22.78% | 4 | Aug 6, 2024 | |
| TDOC Teladoc Health | Maintains: Overweight | $25 → $10 | $9.21 | +8.58% | 4 | Aug 6, 2024 | |
| CI The Cigna Group | Initiates: Overweight | $400 | $316.49 | +26.39% | 1 | Jun 26, 2024 | |
| PINC Premier | Maintains: Neutral | $24 → $22 | $20.28 | +8.48% | 4 | May 8, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $566 → $571 | $567.56 | +0.61% | 4 | Apr 17, 2024 | |
| CVS CVS Health | Maintains: Overweight | $93 → $94 | $55.81 | +68.43% | 3 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $15 | $3.20 | +368.75% | 4 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $42.35 | -45.69% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $2.06 | +2,812.62% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $40 | $18.47 | +116.57% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $48.67 | +43.83% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $9.00 | +677.78% | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $33 | $23.46 | +40.66% | 2 | Nov 4, 2022 |
Humana
Oct 3, 2024
Downgrades: Neutral
Price Target: $392 → $274
Current: $260.71
Upside: +5.10%
Oscar Health
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $17.65
Upside: +58.64%
Health Catalyst
Aug 26, 2024
Maintains: Overweight
Price Target: $14 → $11
Current: $7.70
Upside: +42.86%
MultiPlan
Aug 7, 2024
Reiterates: Neutral
Price Target: $80 → $40
Current: $9.16
Upside: +336.68%
Alignment Healthcare
Aug 6, 2024
Reiterates: Overweight
Price Target: $8 → $10
Current: $12.95
Upside: -22.78%
Teladoc Health
Aug 6, 2024
Maintains: Overweight
Price Target: $25 → $10
Current: $9.21
Upside: +8.58%
The Cigna Group
Jun 26, 2024
Initiates: Overweight
Price Target: $400
Current: $316.49
Upside: +26.39%
Premier
May 8, 2024
Maintains: Neutral
Price Target: $24 → $22
Current: $20.28
Upside: +8.48%
UnitedHealth Group
Apr 17, 2024
Maintains: Overweight
Price Target: $566 → $571
Current: $567.56
Upside: +0.61%
CVS Health
Mar 15, 2024
Maintains: Overweight
Price Target: $93 → $94
Current: $55.81
Upside: +68.43%
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $3.20
Upside: +368.75%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $42.35
Upside: -45.69%
Nov 10, 2023
Downgrades: Neutral
Price Target: $60
Current: $2.06
Upside: +2,812.62%
Sep 12, 2023
Maintains: Overweight
Price Target: $43 → $40
Current: $18.47
Upside: +116.57%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $48.67
Upside: +43.83%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $9.00
Upside: +677.78%
Nov 4, 2022
Maintains: Overweight
Price Target: $40 → $33
Current: $23.46
Upside: +40.66%